Company Data

Aprea Therapeutics Inc.

Ticker
APRE
Current Price
$2.62 -7.75%
Market Cap
$14.2M
Price Target
Refer to Report
Volume
20.2K
52wk Range
$2.1501 - $8.8465
Advanced Market Data

Overview

Aprea Therapeutics Inc is a clinical-stage biopharmaceutical company focused on developing and commercializing cancer therapeutics that reactivate mutant p53 tumor suppressor protein. Its product candidate, APR-246, is a small molecule p53 reactivator that is in late-stage clinical development for hematologic malignancies, including myelodysplastic syndromes (MDS), and acute myeloid leukemia (AML).

Inbox Intel from Channelchek.

Informed investors make more money. And itā€™s all about timing. Get it when it happens.

By clicking submit you are agreeing to the Terms of Use and Privacy Policy